237 related articles for article (PubMed ID: 11427207)
1. Circulating lipoproteins and hepatic sterol metabolism in Psammomys obesus prone to obesity, hyperglycemia and hyperinsulinemia.
Zoltowska M; Ziv E; Delvin E; Stan S; Bar-On H; Kalman R; Levy E
Atherosclerosis; 2001 Jul; 157(1):85-96. PubMed ID: 11427207
[TBL] [Abstract][Full Text] [Related]
2. Non-insulin dependent diabetes mellitus in Psammomys obesus is independent of changes in tissue fatty acid composition.
Collier GR; Collier FM; Sanigorski A; Walder K; Cameron-Smith D; Sinclair AJ
Lipids; 1997 Mar; 32(3):317-22. PubMed ID: 9076669
[TBL] [Abstract][Full Text] [Related]
3. Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats.
Brunet S; Thibault L; Delvin E; Yotov W; Bendayan M; Levy E
Hepatology; 1999 Jun; 29(6):1809-17. PubMed ID: 10347124
[TBL] [Abstract][Full Text] [Related]
4. The role of lipogenesis in the development of obesity and diabetes in Israeli sand rats (Psammomys obesus).
Lewandowski PA; Cameron-Smith D; Jackson CJ; Kultys ER; Collier GR
J Nutr; 1998 Nov; 128(11):1984-8. PubMed ID: 9808653
[TBL] [Abstract][Full Text] [Related]
5. Both insulin resistance and diabetes in Psammomys obesus upregulate the hepatic machinery involved in intracellular VLDL assembly.
Zoltowska M; Ziv E; Delvin E; Lambert M; Seidman E; Levy E
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):118-23. PubMed ID: 14604833
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
[TBL] [Abstract][Full Text] [Related]
7. Islet amyloid polypeptide in Psammomys obesus (sand rat): effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment.
Leckström A; Ziv E; Shafrir E; Westermark P
Pancreas; 1997 Nov; 15(4):358-66. PubMed ID: 9361089
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes.
Bouderba S; Sanchez-Martin C; Villanueva GR; Detaille D; Koceïr EA
J Diabetes; 2014 Mar; 6(2):184-92. PubMed ID: 23953934
[TBL] [Abstract][Full Text] [Related]
9. Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes.
Zoltowska M; Ziv E; Delvin E; Sinnett D; Kalman R; Garofalo C; Seidman E; Levy E
Diabetes; 2003 Oct; 52(10):2539-45. PubMed ID: 14514638
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.
Donath MY; Gross DJ; Cerasi E; Kaiser N
Diabetes; 1999 Apr; 48(4):738-44. PubMed ID: 10102689
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic, normoinsulinaemic state.
Ziv E; Kalman R; Hershkop K; Barash V; Shafrir E; Bar-On H
Diabetologia; 1996 Nov; 39(11):1269-75. PubMed ID: 8932991
[TBL] [Abstract][Full Text] [Related]
12. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus.
Shafrir E; Ziv E; Saha AK; Ruderman NB
Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940
[TBL] [Abstract][Full Text] [Related]
13. Intestinal and hepatic cholesterol carriers in diabetic Psammomys obesus.
Levy E; Lalonde G; Delvin E; Elchebly M; Précourt LP; Seidah NG; Spahis S; Rabasa-Lhoret R; Ziv E
Endocrinology; 2010 Mar; 151(3):958-70. PubMed ID: 20130116
[TBL] [Abstract][Full Text] [Related]
14. beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.
Leibowitz G; Yuli M; Donath MY; Nesher R; Melloul D; Cerasi E; Gross DJ; Kaiser N
Diabetes; 2001 Feb; 50 Suppl 1():S113-7. PubMed ID: 11272167
[TBL] [Abstract][Full Text] [Related]
15. Changing pattern of prevalence of insulin resistance in Psammomys obesus, a model of nutritionally induced type 2 diabetes.
Ziv E; Shafrir E; Kalman R; Galer S; Bar-On H
Metabolism; 1999 Dec; 48(12):1549-54. PubMed ID: 10599987
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of hyperinsulinemia on acyl-CoA:cholesterol acyltransferase activity in the liver and intestine of the rat.
Yang LY; Kuksis A; Steiner G
Atherosclerosis; 1994 May; 107(1):25-34. PubMed ID: 7945556
[TBL] [Abstract][Full Text] [Related]
17. Characterization of stages in development of obesity-diabetes syndrome in sand rat (Psammomys obesus).
Kalderon B; Gutman A; Levy E; Shafrir E; Adler JH
Diabetes; 1986 Jun; 35(6):717-24. PubMed ID: 3519325
[TBL] [Abstract][Full Text] [Related]
18. Vascular responses to alpha-adrenergic stimulation and depolarization are enhanced in insulin-resistant and diabetic Psammomys obesus.
Zoltowska M; St-Louis J; Ziv E; Sicotte B; Delvin EE; Levy E
Can J Physiol Pharmacol; 2003 Jul; 81(7):704-10. PubMed ID: 12897818
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians.
Howard BV
Diabetes Care; 1993 Jan; 16(1):284-91. PubMed ID: 8422793
[TBL] [Abstract][Full Text] [Related]
20. Profile of dyslipidemia in Psammomys obesus, an animal model of the metabolic syndrome.
Walder K; Oakes N; Fahey RP; Cooney G; Zimmet PZ; Collier GR
Endocr Regul; 2002 Mar; 36(1):1-8. PubMed ID: 11971745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
